Hangzhou Royall Import and Export Hangzhou Zhejiang China - Chemical Manufacturers Suppliers Exporters Traders

Hangzhou Royall Import & Export Co. Ltd

Hangzhou Zhejiang China

Hangzhou Royall Import & Export Co. Ltd is located at Hangzhou in China, Zhejiang . They are Distributors, Exporters, Manufacturers, Suppliers, Wholesalers of various chemical items. Their main business regions are Bangladesh, Belarus, Egypt, Russia, USA etc. The chemicals they are supplying mainly used for Chemical Industry, Pharmaceutical Industry . The company established in the year 2012. Their Supplying / Manufacturing Chemical Items are given below :

Hangzhou Royall Import & Export Co. Ltd
Room 1701, Building 3,
Greenland Canal Business Center,
Gongshu District, Hangzhou, China


While you call, Please mention that you got these Phone Numbers from ChemicalBusinessDirectory.com
Phone Numbers
+8613329937817
Please Share This Page :

Company Message

We have established well market channels both domestically and overseas. Now JINLAN PHARMA is authorized by some Chinese chemical factories as universal agency and international area agency. Our products are exported to more than 100 countries and enjoy a well reputation, including Europe, USA, South America, India, south-east Asia and so on. Such as Russia, Canada, Germany, Spain, Australia, UAE, Estonia, Indonesia, Egypt, Pakistan and so on. Our products with Excellent quality, Competitive price, Good after-service, are highly welcomed by our customers.

Activities


Business Regions

Chemical Items

Industrial Usage

WhatsApp

Start WhatsApp Chat


 

Send Message

E-mail :

Captcha to avoid Spam Bots - Pls Calculate Following and Enter the Result :


 

1. What is Hangzhou Royall Import & Export Co. Ltd?

Hangzhou Royall Import & Export Co. Ltd is a company based in Hangzhou, Zhejiang, China, specializing in the export and manufacture of pharmaceuticals, chemical intermediates, biochemicals, veterinary medicines, nutrition products, and related equipment.

2. Where is the company located?

The company is located in Hangzhou, Zhejiang Province, China, with convenient access to Ningbo port, Shanghai port, Hangzhou Xiaoshan International Airport, and Shanghai Pudong International Airport.

3. What are the main business areas of Hangzhou Royall?

The main business areas include Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, custom synthesis, pharmaceutical equipment, peptides, vitamins, contract manufacturing, and contrast agents.

4. Which pharmaceutical equipment does the company supply?

The company supplies distilled water machinery, mixers, sterilizers, reverse osmosis systems, pure steam generators, frame filter presses, MVR, falling film evaporators, CIP systems, mixing tanks, storage tanks, centrifuges, and more.

5. What are the company’s strongest product categories?

Strongest categories include contrast agents, peptides, APIs, vitamins, pharmaceutical intermediates, and custom synthesis services.

6. Which contrast agents does Hangzhou Royall supply?

The company is a leading supplier of contrast agents such as Iohexol, Iopromide, Ioversol, Iopamidol, Iodixanol, Iomeprol, Gadobenate Dimeglumine, Gadopentetate Dimeglumine, Gadoteric acid, Gadodiamide, and Caldiamide Sodium.

7. Does the company offer custom synthesis and contract manufacturing?

Yes, Hangzhou Royall provides custom synthesis and contract manufacturing services for pharmaceutical and chemical products.

8. What is the company’s experience in international trade?

The company exports to more than 100 countries worldwide, including Europe, the USA, South America, India, and Southeast Asia.

9. When was Hangzhou Royall Import & Export Co. Ltd established?

The company was established in 2006.

10. What is the company’s annual turnover?

The company reports an annual turnover ranging from USD 500,000 to nearly 100 million USD.

11. How large is the company’s team?

The company employs around 20 staff members, including specialized chemical technologists and R&D personnel.

12. Does Hangzhou Royall have R&D capabilities?

Yes, the company has strong R&D capabilities and collaborates with science institutes and organizations for technological support and innovation.

13. What is the company’s business philosophy?

The business philosophy is "Human-orient, Technical first, Quality product and High efficiency, Fact and Innovation."

14. What types of clients does the company serve?

The company serves pharmaceutical manufacturers, chemical factories, research institutions, and international distributors.

15. How can potential partners contact Hangzhou Royall Import & Export Co. Ltd?

Potential partners can contact the company through their website (www.royalpharms.com) or by visiting their office at Room 606, Fuyi Center, #298 Quanfuqiao Road, Jianggan Area, Hangzhou, Zhejiang, China.

Comprehensive Internet Overview with AI

  • Company Names Identified:
    • Hangzhou Royall Import & Export Co.,Ltd. (primarily pharmaceuticals/chemicals)
    • Hangzhou Royal Craft Import & Export Co., Ltd. (camping/car accessories)
    • Hangzhou ROYAL PACKING Machinery Co.,Ltd. (corrugated paperboard and carton machinery)
    • Hangzhou Royo Import & Export Co., Ltd. (shower room products)
    • And potentially others with similar names, leading to some ambiguity.
  • Key Business Areas (Based on different entities):
    • Pharmaceuticals & Chemicals (Hangzhou Royall Import & Export Co.,Ltd.):
      • Products: Active Pharmaceutical Ingredients (APIs), Pharmaceutical Intermediates, Custom Synthesis, Biochemicals, Veterinary medicines, Nutrition products. Specific examples include Penicillamine, Vancomycin Hydrochloride, Omeprazole Sodium, Aripiprazole, Paclitaxel, Contrast Agents (Iohexol, Iopromide, etc.), Peptides, Vitamins.
      • Services: Contract manufacturing (CMO/CRO), custom synthesis.
      • Affiliation: Often linked with "Jinlan Pharm-Drugs Technology Co., Limited" as its export company.
      • Markets: Exports to over 100 countries including Europe, USA, South America, India, Southeast Asia.
      • Establishment: Year of establishment around 2005/2006.
      • Annual Turnover: Ranges from USD 0.5 to 1 Million (some sources), to USD 500,000 to 99,999,999 (other sources, possibly for Jinlan Pharm-Drugs as a whole).
      • Employees: 10-50 (some sources), 101-200 (others).
    • Corrugated Paperboard & Carton Machinery (Hangzhou ROYAL PACKING Machinery Co.,Ltd. / Hangzhou Royall Import & Export Co., Ltd.):
      • Products: Corrugated paperboard production machinery, carton machinery, single facer lines, flexo printing machines, folder gluers, stitchers, laminating machines, rotary die-cutting machines, A4 paper production lines, and related spare parts.
      • Focus: TURN-KEY projects for corrugated carton factories and paper mills.
      • Establishment: Founded in the 1990s (for ROYAL PACKING Machinery), with the export company established around 2012.
      • Market: Exports to USA, Germany, Mexico, Korea, India, Turkey, etc.
      • Employees: ~15 employees (for the export company).
      • Certifications: CE certified.
    • Camping & Car Accessories (Hangzhou Royal Craft Import & Export Co., Ltd.):
      • Products: Camping accessories, car accessories, caravan parts, trailer accessories (around 2000 items).
      • Specialization: One-stop supply for RV and trailer accessories.
      • Services: OEM and ODM for products and packaging.
      • Establishment: Founded in 2006.
      • Experience: Over 18 years of export experience in this niche.
      • Main Markets: Europe.
      • Certifications: Electronic items meet EU regulations (CE-EMC, CE-LVD, ROHS, etc.); materials are Phthalates-free, Pahs-free, Sccp-free. Some products TUV/GS approved, E-mark approved.
    • Shower Room Products (Hangzhou Royo Import & Export Co., Ltd.):
      • Products: Shower enclosures, shower trays, bathroom cabinets, LED mirrors.
      • Nature: OEM manufacturer.
      • Annual Export: US $24,157,000.
      • Experience: 15 years in the industry.
      • Certifications: SGS Group.
  • Location:
    • All are based in Hangzhou, Zhejiang Province, China. Specific addresses vary but generally emphasize proximity to Ningbo and Shanghai ports, and Hangzhou Xiaoshan International Airport, indicating excellent transportation logistics.
  • General Company Characteristics (Across various entities):
    • Business Type: Predominantly Trading Company, often acting as the export arm for associated factories/manufacturers (e.g., Jinlan Pharm-Drugs, ROYAL PACKING Machinery). Some also act as manufacturers.
    • Global Reach: Strong export capabilities, with products shipped to numerous countries worldwide.
    • Reputation: Generally claim a "well reputation" or "good reputation" in their respective markets.
    • Customer Focus: Emphasize "good quality products," "competitive prices," and "good after-service."
    • R&D Capacity: Many mention R&D departments, own brands, and ODM/OEM services.
    • Online Presence: Active on major B2B platforms like ExportersIndia, Made-in-China.com, Alibaba.com, ChemNet, and PharmaSources.com.
  • Social Media/Consumer Reviews:
    • Direct consumer reviews or significant social media presence (Facebook, Instagram, YouTube, TikTok) for these B2B-focused import/export companies are largely absent. Their primary engagement is through B2B platforms and direct client relationships.
    • Reviews or feedback are usually found within the context of their supplier profiles on B2B marketplaces (e.g., "Gold Supplier" ratings, "Response Rate" on Alibaba), rather than consumer-facing review sites.
    • Employee reviews on platforms like Glassdoor or LinkedIn are not readily available in public searches for these specific entities.

Opportunities, Demand and Supply Competition Analysis

  • Upcoming New Opportunities:

    • High-Value Pharmaceutical Ingredients:

      • Growing Demand for Diabetes and Obesity Drugs: Products like Semaglutide, Tirzepatide, and Orforglipron are key ingredients in rapidly expanding markets for diabetes and obesity management. The global prevalence of these conditions ensures sustained and increasing demand.
      • Advancements in HIV Treatment: Lenacapavir Sodium and Islatravir are crucial components for new and improved HIV therapies, offering opportunities in a field with ongoing medical innovation and patient needs.
      • Antiviral and Liver Disease Treatments: Oseltamivir Phosphate (antiviral) and Resmetirom (for liver diseases) address significant global health challenges, ensuring continued demand for these APIs.
      • Hepatitis C Treatments: Glecaprevir and Pibrentasvir are components of highly effective Hepatitis C treatments, a market that continues to require accessible and affordable drug ingredients.
    • Custom Synthesis Services:

      • Outsourcing by Pharma Companies: Pharmaceutical companies globally increasingly outsource complex chemical synthesis and API manufacturing to specialized partners to reduce costs and accelerate drug development. This offers a significant opportunity for their custom synthesis services.
      • Demand for Niche and Complex Molecules: As drug discovery becomes more complex, there's a rising need for companies capable of synthesizing challenging and niche molecules, which fits well with custom synthesis capabilities.
    • Emerging Markets Expansion:

      • The increasing healthcare expenditure and demand for affordable medicines in emerging economies globally present significant opportunities for the export of their pharmaceutical ingredients.
  • Demand and Supply Competition (Products and Services):

    • API Manufacturing:

      • Global API Giants: Intense competition from large, established API manufacturers worldwide, particularly from India and other parts of China, who have significant production capacities and economies of scale.
      • Quality and Regulatory Compliance: Competition is heavily influenced by adherence to international quality standards (e.g., GMP) and regulatory approvals (e.g., US FDA, EMA). Companies with a strong compliance record have a competitive edge.
      • Price Competition: For generic APIs, price is a major competitive factor, leading to pressure on margins.
      • Supply Chain Reliability: Ensuring consistent and reliable supply is critical, especially for essential medicines.
    • Custom Synthesis:

      • Specialized CROs/CDMOs: Competition from numerous Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) globally, offering similar custom synthesis and development services.
      • Expertise and IP Protection: Success in custom synthesis depends on specialized chemical expertise, ability to handle complex reactions, and robust intellectual property protection.
      • Speed and Efficiency: The ability to deliver high-quality results quickly is a key differentiator in this service-oriented segment.
  • Role of Hangzhou Royall Import & Export Co. Ltd in the Above Scenario (Positively):

    • Focus on High-Demand APIs: By supplying APIs for blockbuster drugs like Semaglutide and Tirzepatide, they are strategically positioned in high-growth therapeutic areas with significant market demand.
    • Diverse and Relevant Product Portfolio: Their range of APIs covers critical therapeutic areas such as diabetes, obesity, HIV, antivirals, and liver diseases, demonstrating a broad yet targeted approach to the pharmaceutical market.
    • Leveraging Custom Synthesis Capabilities: Offering custom synthesis allows them to serve a wider range of clients, including pharmaceutical companies needing specialized intermediates or novel compounds, thereby diversifying their service offerings and revenue streams.
    • Strategic Location in China: Being based in Hangzhou, Zhejiang, China, provides access to a well-developed chemical and pharmaceutical manufacturing infrastructure, skilled workforce, and efficient supply chains, which can contribute to cost-effectiveness and scalability.
    • Facilitator in Global Supply Chains: As an import and export company, they play a crucial role in connecting Chinese manufacturing capabilities with global pharmaceutical demand, helping to ensure the worldwide supply of essential drug ingredients.